PTC Therapeutics Inc
XBER:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PTC Therapeutics Inc
XBER:BH3
|
US |
|
Q
|
Quanta Services Inc
F:QAA
|
US |
|
T
|
Takkt AG
XBER:TTK
|
DE |
|
D
|
Daimler Truck Holding AG
F:DTG
|
DE |
|
C
|
Canadian Imperial Bank of Commerce
NYSE:CM
|
CA |
Wall St Price Targets
BH3 Price Targets Summary
PTC Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for BH3 is 79.33 EUR with a low forecast of 54.76 EUR and a high forecast of 115.73 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BH3's stock price target?
Price Target
79.33
EUR
According to Wall Street analysts, the average 1-year price target for BH3 is 79.33 EUR with a low forecast of 54.76 EUR and a high forecast of 115.73 EUR.
What is the Revenue forecast for PTC Therapeutics Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for PTC Therapeutics Inc?
Projected CAGR
-4%
The compound annual growth rate for Operating Income over the next 8 years is -4%.
What is the Net Income forecast for PTC Therapeutics Inc?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Net Income has been 70%. The projected CAGR for the next 8 years is -3%.
